{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:05:11Z","timestamp":1747181111598,"version":"3.40.5"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1,13]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Chronic graft versus host disease (cGVHD) is a systemic immune-mediated complication that occurs in approximately half of patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HCT), and remains the leading cause of late morbidity and mortality. cGVHD involves a heterogeneous group of organic manifestations, many of which mimic autoimmune diseases such as scleroderma, primary biliary cholangitis, Sj\u00f6gren syndrome and polymyositis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 60-years-old female with a history of allo-HCT developed <jats:italic toggle=\"yes\">de novo<\/jats:italic> cGVHD 11 months after allo-HCT with isolated liver involvement. The patient presented with jaundice, cytolysis, cholestasis and concomitant acute digital ischemia. Liver biopsy and autoimmunity tests were performed and were found to be compatible with immune-mediated liver damage. Nailfold capillaroscopy revealed microangiopathy, characterized by avascular areas and some enlarged capillaries resembled an early systemic sclerosis pattern.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Biliary cholangitis-like and digital ischemia related to cGVHD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient was treated with high-dose prednisone and ursodeoxycholic acid, and extracorporeal photopheresis. The patient required hospital admission for administration of intravenous prostacyclin due to refractory Raynaud syndrome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>After 6 to 8 weeks, the patient achieved a good response, with evident clinical improvement and progressive normalization of liver function.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>cGVHD is a multiorgan pathological condition, and this case emphasizes that a multidisciplinary team, including rheumatologists, should be involved in the follow-up of allo-transplant patients to ensure that the clinical complications are adequately addressed. Early intervention is critical for improving patient\u2019 prognosis.<\/jats:p>\n            <jats:p>In addition, we performed a systemic literature review based on published case articles on hepatic cGVHD and digital ischemia published up to August 2022. To the best of our knowledge, this is the first reported case of such an association.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000032495","type":"journal-article","created":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T00:54:15Z","timestamp":1673657655000},"page":"e32495","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Critical digital ischemia and biliary cholangitis related to graft versus host disease: A case report and systematic literature review"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5505-7539","authenticated-orcid":false,"given":"Cristina","family":"Hidalgo Calleja","sequence":"first","affiliation":[{"name":"Rheumatology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Salamanca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Alberto","family":"Montilla Morales","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Salamanca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Dolores","family":"S\u00e1nchez Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital Cl\u00ednico Universitario de Valladolid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Pastor Navarro","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Salamanca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Ib\u00e1\u00f1ez Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Salamanca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Conde Ferreiros","sequence":"additional","affiliation":[{"name":"Dermatology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Salamanca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda","family":"L\u00f3pez Corral","sequence":"additional","affiliation":[{"name":"Haematology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Centro de Investigaci\u00f3n del C\u00e1ncer-IBMCC, Salamanca, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/bmt.2009.141","article-title":"Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.","volume":"45","author":"Ljungman","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1158\/0008-5472.CAN-16-1311","article-title":"Allogeneic stem cell transplantation: a historical and scientific overview.","volume":"76","author":"Singh","year":"2016","journal-title":"Cancer Res"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease.","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bbmt.2014.10.021","article-title":"Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the center for international blood and marrow transplant research.","volume":"21","author":"Arai","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/bjh.12115","article-title":"New ways to separate graft-versus-host disease and graft-versus-tumour effects after allogeneic haematopoietic stem cell transplantation.","volume":"160","author":"Kotsiou","year":"2013","journal-title":"Br J Haematol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"DES71","DOI":"10.1167\/iovs.17-23750","article-title":"Sj\u00f6gren\u2019s syndrome, non-Sj\u00f6gren\u2019s syndrome, and graft-versus-host disease related dry eye.","volume":"59","author":"Ogawa","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"e2020002","DOI":"10.4084\/mjhid.2020.002","article-title":"Chronic graft-versus-host-disease-related polymyositis: a 17-months-old child with a rare and late complication of haematopoietic stem cell transplantation.","volume":"12","author":"Chinello","year":"2020","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/039463201002300139","article-title":"Clinical, serologic and instrumental data of ten patients affected by sclerodermatous chronic graft versus host disease: similarities and differences in respect to systemic sclerosis.","volume":"23","author":"Barausse","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fimmu.2016.00118","article-title":"Bone marrow GvHD after allogeneic hematopoietic stem cell transplantation.","volume":"7","author":"Szyska","year":"2016","journal-title":"Front Immunol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/S0140-6736(02)08907-9","article-title":"Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease.","volume":"359","author":"Biedermann","year":"2002","journal-title":"Lancet"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation.","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"667.e1","DOI":"10.1016\/j.jtct.2021.05.022","article-title":"Late-onset acute and chronic graft-versus-host disease in children: clinical features and response to therapy.","volume":"27","author":"Takahashi","year":"2021","journal-title":"Transpl Cell Ther"},{"key":"R13-20250504","first-page":"1","article-title":"Autoimmune complications after hematopoietic stem cell transplantation in children with nonmalignant disorders.","volume":"581657","author":"Khalil","year":"2014","journal-title":"Sci World J"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/cs0640113","article-title":"Relationship between primary biliary cirrhosis and chronic graft versus host disease: investigation of histocompatibility (HLA) antigenic tract antigens.","volume":"64","author":"McFarlane","year":"1983","journal-title":"Clin Sci"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0016-5085(90)91315-W","article-title":"Bhatia P. Secondary biliary cirrhosis as a consequence of graft-versus-host disease.","volume":"98","author":"Stechschulte","year":"1990","journal-title":"Gastroenterology"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/ard.60.11.1046","article-title":"Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients.","volume":"60","author":"Marasini","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0140-6736(80)91621-9","article-title":"Primary biliary cirrhosis is a dry gland syndrome with features of chronic graft-versus-host disease.","volume":"1","author":"Epstein","year":"1980","journal-title":"Lancet"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"747.e1","DOI":"10.1016\/j.jtct.2022.07.017","article-title":"Characterization of hepatic dysfunction in subjects diagnosed with Chronic GVHD by NIH consensus criteria.","volume":"28","author":"Yang","year":"2022","journal-title":"Transpl Cell Ther"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institute of health consensus development project on criteria for clinical trials in chronic graft-versus host disease: I. The 2014 diagnosis and staging working group report.","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"R20-20250504","first-page":"323","article-title":"Development of PBC\/SSc overlap syndrome in chronic GVHD patient: immunological implications in the presence of mitochondrial, nucleolar and spindle midzone autoantigens.","volume":"10","author":"Assandri","year":"2017","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-021-10276-6","article-title":"APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis.","volume":"16","author":"You","year":"2022","journal-title":"Hepatol Int"},{"key":"R22-20250504","first-page":"221","article-title":"Antimitochondrial antibodies in patients with chronic graft-versus-host disease.","volume":"10","author":"Siegert","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1006\/clim.1998.4666","article-title":"Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation.","volume":"91","author":"Quaranta","year":"1999","journal-title":"Clin Immunol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"200","DOI":"10.5045\/kjh.2011.46.3.200","article-title":"Clinical significance of anti-mitochondrial antibodies in a patient with chronic graft-versus-host disease following hematopoietic stem cell transplantation.","volume":"46","author":"Lee","year":"2011","journal-title":"Korean J Hematol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/1024533021000037171","article-title":"Similarity between hepatic graft-versus-host disease and primary biliary cirrhosis.","volume":"7","author":"Wakae","year":"2002","journal-title":"Hematology"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1007\/s10067-019-04745-5","article-title":"Raynaud\u2019s phenomenon-an update on diagnosis, classification and management.","volume":"38","author":"Pauling","year":"2019","journal-title":"Clin Rheumatol"},{"key":"R27-20250504","first-page":"123","article-title":"A review of Raynaud\u2019s disease.","volume":"113","author":"Temprano","year":"2016","journal-title":"Mo Med"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1172\/JCI106565","article-title":"Skin capillary blood flow in scleroderma.","volume":"50","author":"LeRoy","year":"1971","journal-title":"J Clin Invest"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"102458","DOI":"10.1016\/j.autrev.2020.102458","article-title":"Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud\u2019s phenomenon and systemic sclerosis.","volume":"19","author":"Smith","year":"2020","journal-title":"Autoimmun Rev"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/j.1365-2133.2010.09667.x","article-title":"Nailfold capillary abnormalities are prevalent in sclerodermoid graft-versus-host disease and readily detected with dermatoscopy.","volume":"162","author":"Akay","year":"2010","journal-title":"Br J Dermatol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/bmt.2013.106","article-title":"Nailfold capillary abnormalities in sclerodermatous chronic GVHD.","volume":"48","author":"Hofstee","year":"2013","journal-title":"Bone Marrow Transplant"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032495","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:38:38Z","timestamp":1746326318000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,13]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000032495","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2023,1,13]]}}}